In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lilly Control Diabetes Services health systems partnerships will allow billing to Medicare, Medicaid.

Executive Summary

LILLY CONTROL DIABETES SERVICES PARTNERSHIP WITH KENNEDY HEALTH SYSTEM, a New Jersey integrated health care provider, will allow the Lilly subsidiary to bill Medicare and Medicaid for providing interventional services at a jointly operated diabetes education facility, the company said May 22. Control Diabetes Services is unable to bill Medicare or Medicaid directly at its 12 storefront locations.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS030267

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel